Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
Constitutive Aryl Hydrocarbon Receptor Signaling in Prostate Cancer Progression.
Ghotbaddini M, Moultrie V, Powell JB.
J Cancer Treatment Diagn. 2018;2(5):11-16. doi: 10.29245/2578-2967/2018/5.1136. Epub 2018 Oct 9.
Similar articles
Simultaneous inhibition of aryl hydrocarbon receptor (AhR) and Src abolishes androgen receptor signaling.
Ghotbaddini M, Cisse K, Carey A, Powell JB.
PLoS One. 2017 Jul 3;12(7):e0179844. doi: 10.1371/journal.pone.0179844. eCollection 2017.
The AhR Ligand, TCDD, Regulates Androgen Receptor Activity Differently in Androgen-Sensitive versus Castration-Resistant Human Prostate Cancer Cells.
Ghotbaddini M, Powell JB.
Int J Environ Res Public Health. 2015 Jul 6;12(7):7506-18. doi: 10.3390/ijerph120707506.
Cancer-promoting and Inhibiting Effects of Dietary Compounds: Role of the Aryl Hydrocarbon Receptor (AhR).
Powell JB, Ghotbaddini M.
Biochem Pharmacol (Los Angel). 2014 Mar 8;3(1). doi: 10.4172/2167-0501.1000131.
The aryl hydrocarbon receptor is constitutively active in advanced prostate cancer cells.
Richmond O, Ghotbaddini M, Allen C, Walker A, Zahir S, Powell JB.
PLoS One. 2014 Apr 22;9(4):e95058. doi: 10.1371/journal.pone.0095058. eCollection 2014.
Filters: Manage Filters